Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Randomized, Double-Blind, Placebo-Controlled Trial of Effects of Enteral Iron Supplementation on Anemia and Risk of Infection during Surgical Critical Illness
2009
Insulin-Like Growth Factor 2 Promotes Osteogenic Cell Differentiation in the Parthenogenetic Murine Embryonic Stem Cells
2011
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
1998
Heparin-induced thrombocytopenia (HIT)
2006
Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
2004 Standout
Parenteral Anticoagulants
2012 Standout
Can the Nephrologist Prevent Dialysis-Related Amyloidosis?
1991
Bone mineral density may be related to atherosclerosis in hemodialysis patients
2003
Spectrum of acute renal failure in the intensive care unit: The PICARD experience
2004
Peripheral Nerve Amyloidosis
1996
Acute renal failure after exercise in a child with renal hypouricemia
1995
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
2002 StandoutNature
Falls Relate to Vitamin D and Parathyroid Hormone in an Australian Nursing Home and Hostel
1999
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Canadian Hemodialysis Morbidity Study
1992
Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis)
1989
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
2010
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
1996 Standout
Age and origin of the G774A mutation inSLC22A12causing renal hypouricemia in Japanese
2008
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Circulating biochemical markers of bone remodeling in uremic patients
1999
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Risk Factors for Hip Fracture in Hemodialysis Patients
2002
Vitamin D Deficiency
2007 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
Acute renal failure after exercise in a child with renal hypouricaemia
1993
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
2004 Standout
Mortality in Dialysis Patients: Analysis of the Causes of Death
1991
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
Influence of dialysis membranes on outcomes in acute renal failure: A meta-analysis
2002
Heparin-Induced Thrombocytopenia
2006 Standout
Sevelamer Controls Parathyroid Hormone–Induced Bone Disease as Efficiently as Calcium Carbonate without Increasing Serum Calcium Levels during Therapy with Active Vitamin D Sterols
2005
CLINICAL COUNTERPOINT: Vitamin D: New Actions, New Analogs, New Therapeutic Potential*
1992
Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
2000
The development of binary Mg–Ca alloys for use as biodegradable materials within bone
2008 Standout
Systemic amyloidosis
2015 Standout
Septicemia in dialysis patients: Incidence, risk factors, and prognosis
1999
Candidate Genes for Osteoporosis
2001
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Hyperphosphataemia in Renal Failure
2003
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Systematic Review and Meta-analysis
2008 Standout
Calcium kinetics and the long-term effects of lowering dialysate calcium concentration
1993
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Recent advances in bone tissue engineering scaffolds
2012 Standout
Nutrition in Bone Health Revisited: A Story Beyond Calcium
2000
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
2007 Standout
Mucormycosis: association with deferoxamine therapy
1989
Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients
1996
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
A Case Review: Anticoagulation in Hemodialysis Patients with Heparin-Induced Thrombocytopenia
2001
Long-term Use of Oral Anticoagulants and the Risk of Fracture
1999
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Differences in vitamin D status between countries in young adults and the elderly
1992
Pharmacokinetics of vitamin D toxicity
2008
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study
2000
Chronic Kidney Disease
2016 Standout
Molecular Mechanisms of Amyloidosis
2003 Standout
Long‐Term Citrate Anticoagulation for High‐Flux Haemodialysis in a Patient with Heparin‐Induced Thrombocytopenia Type II
2002
The dawning era of polymer therapeutics
2003 Standout
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Determination of 25-Hydroxyvitamin D in Human Plasma Using High-Performance Liquid Chromatography−Tandem Mass Spectrometry
2005
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis.
1998
Magnesium in Man: Implications for Health and Disease
2014 Standout
Managing phosphate retention: is a change necessary?
2000
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
2007 Standout
Zygomycetes in Human Disease
2000 Standout
Primary Biliary Cirrhosis
1987 Standout
Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Origin of the PSEN1 E280A mutation causing early‐onset Alzheimer's disease
2013 StandoutNobel
25-Hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol.
1977
Renal replacement therapy in patients with acute renal failure: a systematic review.
2008
Vitamin D and Immune Function
2013 Standout
Comparison of Survival Probabilities for Dialysis Patients vs Cadaveric Renal Transplant Recipients
1993 Standout
Contribution of Bleeding and Thromboembolic Events to In-Hospital Mortality Among Patients With Thrombocytopenia Treated With Heparin
2009
The Role of Vitamin D in Cancer Prevention
2005 Standout
ABSORPTION, HYDROXYLATION, AND EXCRETION OF VITAMIN D3 IN PRIMARY BILIARY CIRRHOSIS
1977
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
Intestinal Cholecalciferol Absorption in the Elderly and in Younger Adults
1978
Light and electron microscopy immunohistochemical characterization of amyloid deposits
1997
Intestinal absorption of calcium and the effect of renal insufficiency
1973
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Bone metabolism and disease in chronic kidney disease
2003
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone
1999
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Works of K. Schaefer being referenced
Iron Overload, but not Treatment with Desferrioxamine Favours the Development of Septicemia in Patients on Maintenance Hemodialysis
1987
Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis
1993
The Treatment of Uraemic Hyperphosphataemia with Calcium Acetate and Calcium Carbonate: A Comparative Study
1991
Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia
1989
Beta-2-Microglobulin-Derived Amyloidosis: Onset, Distribution and Clinical Features in 13 Hemodialysed Patients
1992
Bone Fracture History and Prospective Bone Fracture Risk of Hemodialysis Patients are Related to Apolipoprotein E Genotype
1998
Is the Choice of Membrane Important for Patients with Acute Renal Failure Requiring Hemodialysis?
1995
Different Handling of Beta<sub>2</sub>-Microglobulin during Hemodialysis and Hemofiltration
1988
Reduced Risk of Hypercalcemia for Hemodialysis Patients by Administering Calcitriol at Night
1992
Bone health of adult hemodialysis patients is related to vitamin K status
1997
Alternative phosphate binders: an update
1993
The Metabolic Fate of (26,27) 3H‐25‐Hydroxyvitamin D3 in Normal, Uremic and Rachitic Rats
1972
Calcium Acetate: New Hope in the Treatment of Uremic Hyperphosphatemia?
1990
Serum 25-Hydroxycholecalciferol in Uremia
1974
Calcium salts of ketoacids as a new treatment strategy for uremic hyperphosphatemia.
1989
The Metabolism of Isotopically Labelled Vitamin D3 in Man: The Influence of the State of Vitamin D Nutrition
1971
Digoxin-quinidine interaction in patients with renal failure
1981
Immunoreaktives Parathormon, 25-Hydroxycalciferol und Knochenhistologie bei renaler Osteopathie
1976
Metabolism of 1,2 H 3 -4-C 14 -cholecalciferol in normal, uremic and anephric subjects.
1972
Bone fracture risk in haemodialysis patients is related to apolipoprotein E (APOE) genotype, A modulator of vitamin k status
1996
Hypercalcemia and elevated serum 1,25-dihydroxyvitamin D3 in a patient with hodgkin's lymphoma
1986
Optimum dialysis treatment for patients over 60 years with primary renal disease. Survival data and clinical results from 242 patients treated either by haemodialysis or haemofiltration.
1985